Cancer Control

A221805

Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study

---

URCC 16070 (Temporarily Suspended)

Treatment of Refractory Nausea

---